← Open Payments lookup

KALEIGH O'NEIL: Open Payments

NPI 1831765296 · LEOMINSTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,482 in 68 payments from 12 companies in 2025. Trend: 2023 $1,420 · 2024 $1,679 · 2025 $1,482

Food & beverage: $1,349Education: $133
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.23$372
AstraZeneca Pharmaceuticals LP9$348
Amgen Inc.8$166
GENZYME CORPORATION10$161
Novartis Pharmaceuticals Corporation5$114
GC Biopharma USA, Inc.3$94
GlaxoSmithKline, LLC.2$53
ARS Pharmaceuticals Operations, Inc.3$51
Lilly USA, LLC2$48
CSL Behring1$33

Products named: DUPIXENT, TEZSPIRE, FASENRA, AIRSUPRA, ALYGLO, NUCALA, NEFFY, EBGLYSS.

Industry payments across MA — which companies pay providers there.